Profile | GDS4284 / 1555752_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 246.042 | 53 |
GSM687648 | Patient 402 control | 223.621 | 51 |
GSM687653 | Patient 403 control | 263.181 | 55 |
GSM687658 | Patient 404 control | 192.633 | 48 |
GSM687663 | Patient 411 control | 224.497 | 50 |
GSM687668 | Patient 422 control | 326.72 | 57 |
GSM687673 | Patient 424 control | 237.804 | 50 |
GSM687678 | Patient 425 control | 83.3079 | 30 |
GSM687683 | Patient 427 control | 249.847 | 51 |
GSM687688 | Patient 428 control | 219.401 | 50 |
GSM687695 | Patient 441 control | 655.961 | 67 |
GSM687699 | Patient 443 control | 450.458 | 61 |
GSM687704 | Patient 444 control | 199.388 | 48 |
GSM687707 | Patient 448 control | 253.369 | 50 |
GSM687712 | Patient 449 control | 163.597 | 44 |
GSM687719 | Patient 450 control | 295.505 | 53 |
GSM687724 | Patient 451 control | 252.426 | 51 |
GSM687728 | Patient 452 control | 307.004 | 55 |
GSM687646 | Patient 401 treated 24h | 184.943 | 46 |
GSM687649 | Patient 402 treated 24h | 134.731 | 42 |
GSM687665 | Patient 411 treated 24h | 270.576 | 52 |
GSM687651 | Patient 402 treated 4 weeks | 306.593 | 55 |
GSM687667 | Patient 411 treated 4 weeks | 224.531 | 50 |
GSM687670 | Patient 422 treated 24h | 326.058 | 56 |
GSM687671 | Patient 422 treated 4 weeks | 195.068 | 48 |
GSM687654 | Patient 403 treated 24h | 260.912 | 55 |
GSM687675 | Patient 424 treated 24h | 242.479 | 50 |
GSM687685 | Patient 427 treated 24h | 120.06 | 38 |
GSM687656 | Patient 403 treated 4 weeks | 210.045 | 51 |
GSM687677 | Patient 424 treated 4 weeks | 173.805 | 46 |
GSM687687 | Patient 427 treated 4 weeks | 151.189 | 45 |
GSM687692 | Patient 428 treated 4h | 174.417 | 45 |
GSM687716 | Patient 449 treated 4h | 172.345 | 46 |
GSM687722 | Patient 450 treated 4h | 305.008 | 54 |
GSM687680 | Patient 425 treated 24h | 220.047 | 50 |
GSM687690 | Patient 428 treated 24h | 112.118 | 37 |
GSM687700 | Patient 443 treated 24h | 395.12 | 56 |
GSM687705 | Patient 444 treated 24h | 152.397 | 45 |
GSM687714 | Patient 449 treated 24h | 190.702 | 49 |
GSM687721 | Patient 450 treated 24h | 333.824 | 55 |
GSM687682 | Patient 425 treated 4 weeks | 123.882 | 40 |
GSM687694 | Patient 428 treated 4 weeks | 222.712 | 52 |
GSM687702 | Patient 443 treated 4 weeks | 377.246 | 58 |
GSM687718 | Patient 449 treated 4 weeks | 221.778 | 50 |
GSM687723 | Patient 450 treated 4 weeks | 285.592 | 54 |
GSM687661 | Patient 404 treated 4h | 259.6 | 52 |
GSM687710 | Patient 448 treated 4h | 226.859 | 51 |
GSM687726 | Patient 451 treated 4h | 266.106 | 51 |
GSM687730 | Patient 452 treated 4h | 1061.35 | 75 |
GSM687660 | Patient 404 treated 24h | 293.19 | 53 |
GSM687697 | Patient 441 treated 24h | 370.695 | 56 |
GSM687709 | Patient 448 treated 24h | 165.886 | 43 |
GSM687725 | Patient 451 treated 24h | 271.188 | 51 |
GSM687729 | Patient 452 treated 24h | 250.698 | 47 |
GSM687727 | Patient 451 treated 4 weeks | 258.965 | 51 |
GSM687731 | Patient 452 treated 4 weeks | 350.375 | 57 |